logo

For the Inventor, By the Inventor

St. Louis, MO, United States of America

Niraj H Tolia

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Washington University, University of South Florida, Case Western Reserve University. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niraj H Tolia. Retrieved from https://idiyas.com/inventor/niraj-h-tolia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 8.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal5 out of 1,383 
 
Washington University
 patents
silverMedal4 out of 1,993 
 
University of South Florida
 patents
bronzeMedal3 out of 1,368 
 
Case Western Reserve University
 patents
where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...
5 patents (USPTO):Explore Patents
1. 12404311 - Synthetic plasmodium antigens, compositions, and uses thereof (2025-09-02),
2. 12398184 - Compositions comprising CelTOS immunogens and antibodies and method of use thereof (2025-08-26),
3. 11787845 - Synthetic plasmodium antigens, compositions, and uses thereof (2023-10-17),
4. 10927153 - Synthetic plasmodium antigens, compositions, and uses thereof (2021-02-23),
5. 10273468 - Inhibition and diagnostics of emerging tetracycline resistance enzymes (2019-04-30),

Title: The Innovative Contributions of Niraj H Tolia

Introduction

Niraj H Tolia is a prominent inventor based in St. Louis, MO (US), known for his significant contributions to the field of synthetic antigens and immunology. With a total of 5 patents, Tolia has made remarkable strides in developing methods and compositions for treating and preventing diseases.

Latest Patents

Among his latest patents, Tolia has developed synthetic plasmodium antigens, compositions, and uses thereof. This patent provides synthetic antigens, antibodies, and pharmaceutical formulations, including vaccines, aimed at treating and preventing infections and diseases. Another notable patent focuses on immunogenic compositions and methods for vaccination with a CelTOS immunogen. This composition may include CelTOS with structural changes that enhance immune recognition.

Career Highlights

Throughout his career, Tolia has worked with esteemed institutions such as Washington University and the University of South Florida. His work has been pivotal in advancing the understanding and application of immunogenic compositions in medical science.

Collaborations

Tolia has collaborated with notable colleagues, including John H Adams and Nichole Diane Salinas, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Niraj H Tolia's innovative work in synthetic antigens and immunology showcases his dedication to advancing medical science. His patents reflect a commitment to developing effective treatments and preventive measures against diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…